載入...
Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended...
Na minha lista:
| 發表在: | Clin Diabetes |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Diabetes Association
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4220591/ https://ncbi.nlm.nih.gov/pubmed/25646943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaclin.32.4.170 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|